MF85

ICD-11 MMS 2026-01

Anti-glomerular basement membrane antibody mediated disease

Description

Anti-GBM mediated glomerulonephritis is an aggressive focal and segmental proliferative glomerular disease characterised by linear staining of the glomerular basement membrane for immunoglobulins, particularly IgG and IgM. Crescentic change is often associated and circulating anti-bodies to glomerular basement membrane are found in active disease. The renal syndrome is often acute nephritis with rapid renal functional decline (rapidly progressive nephritis) and if associated with respiratory involvement (haemoptysis, respiratory failure) the couple is termed “Goodpasture's syndrome”.

Index terms

  • Anti-glomerular basement membrane antibody mediated disease
  • Anti-glomerular basement membrane antibody disease
  • Goodpasture syndrome

Inclusions

  • Goodpasture syndrome

Exclusions from above levels

  • 19 – Certain conditions originating in the perinatal period
  • JA66 – Clinical findings on antenatal screening of mother

Sibling codes

  • MF80 – Diffuse mesangial sclerosis
  • MF81 – Fibronectin glomerulopathy
  • MF82 – Lipoprotein glomerulopathy
  • MF83 – Diabetic glomerular changes
  • MF84 – Pauci-immune proliferative glomerulonephritis
  • MF8Y – Other specified clinical findings in specimens from the urinary system
  • MF8Z – Clinical findings in specimens from the urinary system, unspecified

Foundation entity

Anti-glomerular basement membrane antibody mediated disease – http://id.who.int/icd/entity/591736785

Part of: 21: Symptoms, signs or clinical findings, not elsewhere classified